American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain
- MeSH Terms
- Chronic Pain (C10.597.617.258); Chronic Pain (C23.888.592.612.274); Guidelines as Topic (N04.761.700.350); Guidelines as Topic (N05.700.350); Practice Guidelines as Topic (N04.761.700.350.650); Practice Guidelines as Topic (N05.700.350.650); Health Planning Guidelines (N03.349.315); Analgesics; Opioid (D27.505.954.427.040.550.500); Analgesics; Opioid (D27.505.696.277.600.500); Analgesics; Opioid (D27.505.954.427.210.600.500); Analgesics; Opioid (D27.505.696.663.850.014.760.500); Pain Management (E02.745); Pain Management (N04.590.607.500); Analgesics (D27.505.696.663.850.014); Analgesics (D27.505.954.427.040); Analgesics; Non-Narcotic (D27.505.696.663.850.014.040); Analgesics; Non-Narcotic (D27.505.954.427.040.100); Child (M01.060.406); Acute Pain (C10.597.617.088); Acute Pain (C23.888.646.115)
- Guideline Contact
- [email protected]
- Publication Scope
- management
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- ASH (US) American Society of Hematology
- Publication Year
- 2020
